0001104659-20-076463.txt : 20200624 0001104659-20-076463.hdr.sgml : 20200624 20200624164902 ACCESSION NUMBER: 0001104659-20-076463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200623 FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rajah Vignesh CENTRAL INDEX KEY: 0001815042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 20986125 MAIL ADDRESS: STREET 1: HENRIKSHOJ 8 STREET 2: ROOM 4 CITY: VEDBAEK STATE: G7 ZIP: DK-2950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 750 THIRD AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4 1 a4.xml 4 X0306 4 2020-06-23 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001815042 Rajah Vignesh C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 0 1 0 0 SVP & CMO Employee Stock Option (right to buy) 48.67 2020-06-23 4 A 0 40000 0 A 2030-06-23 Common stock 40000 40000 D Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. The stock option shall vest and become exercisable as to 25% of the shares subject to the option on June 23, 2021, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. /s/ Vignesh Rajah 2020-06-24